What is the current price and short-term outlook for 4551.T stock?

4551.T stock is at **JPY 6,350.00** pre-market on 10 Feb 2026. Short-term outlook shows an oversold bounce setup with support at **JPY 6,330.00** and resistance near **JPY 6,500.00**; trade with a stop near **JPY 6,200.00**.

How does valuation for 4551.T stock compare to the healthcare sector?

4551.T stock trades at a **PE of 33.00**, above the sector average PE of **24.12**, with a **price-to-book of 1.46**. The premium reflects specialty products and stable margins versus larger peers.

What do Meyka AI forecasts say about 4551.T stock?

Meyka AI's forecast model projects **JPY 5,526.11** (yearly) and **JPY 6,581.12** (3 years). Yearly projection implies **-12.97%**, three-year implies **+3.64%** versus current **JPY 6,350.00**. Forecasts are model-based and not guarantees.

Which catalysts could move 4551.T stock?

Key catalysts: product uptake (REMITCH, CORECTIM), regulatory updates, and the earnings release on **2025-07-29**. Sector news from larger healthcare names can also influence sentiment for 4551.T stock.

JP Stocks

4551.T Torii Pharmaceutical (JPX) JPY 6,350 pre-market 10 Feb 2026: bounce

ByHuzaifa Zahoor February 9, 2026February 9, 2026

4551.T stock trades at JPY 6,350.00 in the pre-market on 10 Feb 2026, setting up a clear oversold bounce opportunity for short-term traders. Volume is 48,100.00 shares and the intraday range is JPY 6,330.00–6,350.00, suggesting thin pre-market trade. Torii Pharmaceutical Co., Ltd. (JPX) shows a PE of 33.00 and EPS of 192.43, while balance-sheet ratios point to strong liquidity with a current ratio of 5.18. We outline a concise trade plan, valuation context, and Meyka AI forecast comparison for investors watching the rebound.